Details for Patent: 10,314,788

Which drugs does patent 10,314,788 protect, and when does it expire?

Patent 10,314,788 protects MORPHABOND ER and ROXYBOND and is included in two NDAs.

This patent has twenty-three patent family members in ten countries.

Summary for Patent: 10,314,788

Title:	Pharmaceutical compositions configured to deter dosage form splitting
Abstract:	An oral pharmaceutical composition comprising a drug and one or more pharmaceutically acceptable excipients in a monolithic dosage form, wherein the dosage form is configured such that when the dosage form is divided into more than one piece and at least one of the pieces is administered to a subject the Cmax, AUC, and/or rate of drug released after administration is substantially the same or lower and the Tmax is higher than the Cmax, AUC, rate of drug released, and/or Tmax after administration of: (1) a comparable composition in intact dosage form of equal drug dosage of the administered at least one piece; (2) a bioequivalent drug composition in an intact dosage form of equal drug dosage to the administered at least one piece; and (3) a divided piece of a bioequivalent drug composition, wherein the divided piece comprises a drug dosage equal to the dosage of the administered piece of the oral composition. Methods of making the same and methods of using the same are also provided.
Inventor(s):	Shah; Manish S. (Valley Cottage, NY), Difalco; Ray J. (Valley Cottage, NY)
Assignee:	INSPIRION DELIVERY SCIENCES LLC (Basking Ridge, NJ)
Application Number:	13/058,757
Patent Claim Types: see list of patent claims	Composition; Dosage form;

Drugs Protected by US Patent 10,314,788

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-001	Oct 2, 2015		DISCN	Yes	No			Y
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-002	Oct 2, 2015		DISCN	Yes	No			Y
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-003	Oct 2, 2015		DISCN	Yes	No			Y
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-004	Oct 2, 2015		DISCN	Yes	No			Y
Protega Pharms	ROXYBOND	oxycodone hydrochloride	TABLET;ORAL	209777-001	Apr 20, 2017		RX	No	No			Y
Protega Pharms	ROXYBOND	oxycodone hydrochloride	TABLET;ORAL	209777-004	Sep 5, 2024		RX	No	No			Y
Protega Pharms	ROXYBOND	oxycodone hydrochloride	TABLET;ORAL	209777-002	Apr 20, 2017		RX	No	No			Y

Foreign Priority and PCT Information for Patent: 10,314,788

PCT Information
PCT Filed	February 12, 2009	PCT Application Number:	PCT/US2009/033919
PCT Publication Date:	February 18, 2010	PCT Publication Number:	WO2010/019279

International Family Members for US Patent 10,314,788

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2008286914
Australia	2009282376
Australia	2015200009
Australia	2017200414
Australia	2019200895
Brazil	PI0815387
Canada	2696341